On January 8th, a filing revealed that Representative Jonathan L. Jackson (D-Illinois) disposed of between $15,001 and $50,000 in MercadoLibre shares on December 10th. The transaction was executed through his Morgan Stanley Trust Account, marking his latest move in a series of high-profile trades. Jackson, who assumed office in January 2023 and is seeking re-election in 2026, has diversified his portfolio recently, including purchases in Palantir Technologies and Tenet Healthcare and sales in Robinhood Markets and Netflix. His divestiture of MercadoLibre stock highlights potential shifts in institutional sentiment toward Latin American growth names within political portfolios.

MercadoLibre’s latest quarterly report, released October 29th, showed revenue of $7.41 billion, exceeding consensus estimates of $7.19 billion and rising 39.5% year-over-year. However, earnings per share came in at $8.32, missing the Street estimate of $9.88 by $1.56. The company reported a net margin of 7.93% and a return on equity of 39.03%. Balance-sheet metrics remain solid, with a debt-to-equity ratio of 0.55, a current ratio of 1.17 and a quick ratio of 1.15. With a market capitalization of $110.45 billion, a price-to-earnings ratio of 53.16 and a beta of 1.42, the firm continues to navigate high-growth markets despite near-term profit pressure.

Major money managers have made modest adjustments to their MercadoLibre positions: Range Financial Group boosted its holding by 2.7%, E Fund Management Hong Kong by 26.3%, and Quadcap Wealth Management by 4.2% in the second quarter, each adding five shares. Meanwhile, insiders have sold a total of 1,136 shares valued at $2.31 million over the last 90 days. Directors Emiliano Calemzuk and Stelleo Tolda reduced their stakes by 14.9% and 246 shares respectively, raising questions about insider conviction as the firm approaches a one-year high of $2,645.22 and low of $1,723.90.

Among 20 recent research notes, one analyst assigned a Strong Buy rating, 15 labeled MercadoLibre a Buy, three issued Holds and one recommended Sell. The consensus rating is Moderate Buy with an average price target of $2,842.94. Notable recent revisions include BTIG Research’s reiteration of a Buy rating with a $2,750 objective and Barclays’ upgrade to Overweight with a target raised to $2,900. Citigroup and UBS Group adjusted targets downward to $2,700 and $2,900 respectively, reflecting concerns over valuation and emerging-market volatility.